Life Scientist > Biotechnology

The antibiotic potential of CBD

03 February, 2021

Researchers have shown that synthetic cannabidiol — better known as CBD — can kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease.


Novavax COVID-19 vaccine demonstrates 89.3% efficacy

31 January, 2021

NVX-CoV2373, a protein-based COVID-19 vaccine candidate, has demonstrated efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.


TGA approves Pfizer and BioNTech's COVID-19 vaccine

25 January, 2021

The Therapeutic Goods Administration (TGA) has granted provisional approval to Pfizer Australia for its COVID-19 vaccine, developed in partnership with BioNTech.


8 myths about mRNA COVID-19 vaccines explained

20 January, 2021

Dr Thaddeus Stappenbeck dispels fears about the new generation of vaccines and explains that they cannot alter your DNA or give you COVID-19.


Drug inhibits cancer cell growth by attacking mitochondria

15 January, 2021

A newly developed compound starves cancer cells by attacking their 'power plants', by preventing the genetic information within mitochondria from being read.


Oral insulin nanoparticles could replace injections

14 January, 2021

Scientists have developed insulin nanoparticles that may one day become the basis for an oral medicine — and an alternative to insulin injections for diabetic patients.


Aus COVID-19 vaccine rollout brought forward to February

08 January, 2021

Prime Minister Scott Morrison says the first groups are expected to receive a jab as early as the middle of the month.


Innovative enclosed blood collection system

01 January, 2021

This system allows the user to draw blood from the patient using the aspiration or vacuum technique.


Why Australia is a prime destination for drug discovery projects

23 December, 2020

There are several compelling reasons why companies should consider Australia as the best location for their next chemistry and drug development partnership.


New polio vaccine is more genetically stable

17 December, 2020

Scientists have developed the first poliovirus vaccine against a mutated form of the disease that is causing disease outbreaks across Africa and Asia.


New insulin molecule can self-regulate blood sugar

15 December, 2020

A new insulin molecule should make blood sugar regulation both easier and safer for those with type 1 diabetes, ensuring they receive just the right amount of insulin.


Brain implants could restore rudimentary vision in the blind

14 December, 2020

Restoration of vision in blind people is on the verge of becoming reality, with high-resolution implants making it possible to recognise artificially induced shapes and percepts.


UQ COVID-19 vaccine dropped after false positive HIV results

11 December, 2020 by Lauren Davis

UQ and CSL's COVID-19 vaccine candidate will not proceed to Phase 2/3 clinical trials following reports of false positive HIV results in study volunteers.


Oxford first to publish peer-reviewed COVID-19 vaccine results

09 December, 2020

Interim results of the University of Oxford's COVID-19 vaccine Phase 3 trials find that the vaccine protects against symptomatic disease in 70% of cases on average.


Moderna vaccine reports 100% efficacy against severe COVID-19

02 December, 2020

Primary efficacy analysis of the Phase 3 study of Moderna's COVID-19 vaccine candidate, mRNA-1273, has confirmed a vaccine efficacy of 94.1%.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd